Search
for
Sort by
Research 211–240 of 420
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Thyroid hormones and androgens differentially regulate gene expression in testes and ovaries of sexually mature Silurana tropicalis
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Effect of <i>Ficus carica</i> leaf extract on the gene expression of selected factors in HaCaT cells
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- Genetic basis of polycystic ovary syndrome
- The endocrinology of baldness
- Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss
- Effects on Steroid 5-Alpha Reductase Gene Expression of Thai Rice Bran Extracts and Molecular Dynamics Study on SRD5A2
- 5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Bilateral temporal alopecia in male androgenetic alopecia: An unusual new presentation
- Genetic and other epidemiological risk factors of infants and children with hypospadias: a case control study
- Pumpkin Seed Oil-Loaded Niosomes for Topical Application: 5α-Reductase Inhibitory, Anti-Inflammatory, and In Vivo Anti-Hair Loss Effects
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- Post-finasteride syndrome – does it really exist?
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Androgens in women
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Female Pattern Hair Loss
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024